Eton Pharmaceuticals Cash Flow Statement
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Eton Pharmaceuticals free cash flow
In fiscal 2025, Eton Pharmaceuticals generated $10.5 million of operating cash flow and spent $333,000 on capital expenditures. That left free cash flow of $10.2 million, a free-cash-flow margin of 12.7% of revenue. Free cash flow was up 980.7% from the prior year's $943,000.
Summary generated from market data by MetaCap's automated system. Methodology
Eton Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4.60M | -3.82M | -936.00K | -9.02M | -1.96M | -27.97M | -18.32M | -12.74M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 4.04M | 1.15M | 901.00K | 66.00K | 155.00K | 347.00K | 283.00K | 63.00K |
| Stock-Based Compensation | 5.51M | 3.17M | 3.14M | 4.22M | 3.38M | 2.58M | 1.89M | 1.85M |
| Change in Working Capital | -6.42M | -4.50M | 696.00K | 6.89M | -6.21M | 1.01M | -2.06M | 99.00K |
| Operating Cash Flow | 10.52M | 969.00K | 6.82M | 4.82M | -4.72M | -22.35M | -18.03M | -8.14M |
| Capital Expenditures | -333.00K | -26.00K | 0 | -38.00K | -9.00K | -50.00K | -1.10M | -236.00K |
| Investing Cash Flow | -333.00K | -40.01M | -775.00K | -2.79M | -2.56M | -50.00K | -1.85M | -236.00K |
| Debt Issued | 0 | 25.31M | 0 | 0 | — | 1.97M | 4.75M | — |
| Debt Repaid | 0 | -1.16M | -1.16M | -385.00K | -150.00K | — | — | — |
| Financing Cash Flow | 815.00K | 32.59M | -957.00K | -134.00K | 391.00K | 31.63M | 5.20M | 21.96M |
| Net Change in Cash | 11.01M | -6.45M | 5.08M | 1.90M | -6.89M | 9.23M | -14.67M | 13.58M |
| Free Cash Flow | 10.19M | 943.00K | 6.82M | 4.78M | -4.73M | -22.40M | -19.12M | -8.38M |
This table shows 8 annual periods of Eton Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2018, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ETON's reporting calendar. What is a cash flow statement?